Logo image of 1BA.MI

BOEING CO/THE (1BA.MI) Stock Fundamental Analysis

BIT:1BA - Euronext Milan - US0970231058 - Common Stock - Currency: EUR

160.02  +19.68 (+14.02%)

Fundamental Rating

1

1BA gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 39 industry peers in the Aerospace & Defense industry. 1BA has a bad profitability rating. Also its financial health evaluation is rather negative. 1BA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

1BA had negative earnings in the past year.
1BA had a negative operating cash flow in the past year.
In the past 5 years 1BA always reported negative net income.
In multiple years 1BA reported negative operating cash flow during the last 5 years.
1BA.MI Yearly Net Income VS EBIT VS OCF VS FCF1BA.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B

1.2 Ratios

With a Return On Assets value of -7.45%, 1BA is not doing good in the industry: 84.62% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -7.45%
ROE N/A
ROIC N/A
ROA(3y)-4.27%
ROA(5y)-4.73%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1BA.MI Yearly ROA, ROE, ROIC1BA.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for 1BA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
1BA.MI Yearly Profit, Operating, Gross Margins1BA.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

More info and screens

1

2. Health

2.1 Basic Checks

1BA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, 1BA has more shares outstanding
1BA has more shares outstanding than it did 5 years ago.
1BA has a better debt/assets ratio than last year.
1BA.MI Yearly Shares Outstanding1BA.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
1BA.MI Yearly Total Debt VS Total Assets1BA.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

Based on the Altman-Z score of 1.06, we must say that 1BA is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.06, 1BA is doing worse than 82.05% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.06
ROIC/WACCN/A
WACC9.28%
1BA.MI Yearly LT Debt VS Equity VS FCF1BA.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B

2.3 Liquidity

1BA has a Current Ratio of 1.23. This is a normal value and indicates that 1BA is financially healthy and should not expect problems in meeting its short term obligations.
1BA has a Current ratio (1.23) which is in line with its industry peers.
A Quick Ratio of 0.37 indicates that 1BA may have some problems paying its short term obligations.
The Quick ratio of 1BA (0.37) is worse than 92.31% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 0.37
1BA.MI Yearly Current Assets VS Current Liabilites1BA.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

More info and screens

3

3. Growth

3.1 Past

1BA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -247.36%.
1BA shows a decrease in Revenue. In the last year, the revenue decreased by -9.15%.
1BA shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.74% yearly.
EPS 1Y (TTM)-247.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.64%
Revenue 1Y (TTM)-9.15%
Revenue growth 3Y2.21%
Revenue growth 5Y-4.74%
Sales Q2Q%17.67%

3.2 Future

The Earnings Per Share is expected to grow by 18.96% on average over the next years. This is quite good.
1BA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.88% yearly.
EPS Next Y90.79%
EPS Next 2Y47.89%
EPS Next 3Y32.88%
EPS Next 5Y18.96%
Revenue Next Year25.26%
Revenue Next 2Y20.57%
Revenue Next 3Y17.11%
Revenue Next 5Y13.88%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
1BA.MI Yearly Revenue VS Estimates1BA.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50B 100B 150B
1BA.MI Yearly EPS VS Estimates1BA.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 -10 -20

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

1BA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 47.59, 1BA can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, 1BA is valued a bit more expensive than 74.36% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of 1BA to the average of the S&P500 Index (20.81), we can say 1BA is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 47.59
1BA.MI Price Earnings VS Forward Price Earnings1BA.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
1BA.MI Per share data1BA.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
1BA's earnings are expected to grow with 32.88% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.89%
EPS Next 3Y32.88%

More info and screens

0

5. Dividend

5.1 Amount

1BA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BOEING CO/THE

BIT:1BA (4/29/2025, 7:00:00 PM)

160.02

+19.68 (+14.02%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)04-23 2025-04-23/bmo
Earnings (Next)07-29 2025-07-29/bmo
Inst Owners75.41%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap120.66B
Analysts78.92
Price Target171.07 (6.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-14.51%
Min EPS beat(2)-91.07%
Max EPS beat(2)62.06%
EPS beat(4)2
Avg EPS beat(4)-17.04%
Min EPS beat(4)-91.07%
Max EPS beat(4)62.06%
EPS beat(8)5
Avg EPS beat(8)2.39%
EPS beat(12)5
Avg EPS beat(12)-793.25%
EPS beat(16)6
Avg EPS beat(16)-758.23%
Revenue beat(2)0
Avg Revenue beat(2)-5.58%
Min Revenue beat(2)-8.71%
Max Revenue beat(2)-2.46%
Revenue beat(4)0
Avg Revenue beat(4)-4.73%
Min Revenue beat(4)-8.71%
Max Revenue beat(4)-2.46%
Revenue beat(8)2
Avg Revenue beat(8)-2.12%
Revenue beat(12)2
Avg Revenue beat(12)-3.61%
Revenue beat(16)2
Avg Revenue beat(16)-5.07%
PT rev (1m)-7.49%
PT rev (3m)-6.37%
EPS NQ rev (1m)-37.45%
EPS NQ rev (3m)-487.66%
EPS NY rev (1m)2.79%
EPS NY rev (3m)-37216.3%
Revenue NQ rev (1m)-2.41%
Revenue NQ rev (3m)-1.97%
Revenue NY rev (1m)-0.22%
Revenue NY rev (3m)-0.28%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 47.59
P/S 1.97
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-17.39
EYN/A
EPS(NY)3.36
Fwd EY2.1%
FCF(TTM)-14.92
FCFYN/A
OCF(TTM)-12.08
OCFYN/A
SpS81.2
BVpS-3.89
TBVpS-15.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.45%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.27%
ROA(5y)-4.73%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 130.38%
Cap/Sales 3.49%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 0.37
Altman-Z 1.06
F-Score3
WACC9.28%
ROIC/WACCN/A
Cap/Depr(3y)90.02%
Cap/Depr(5y)74.76%
Cap/Sales(3y)2.43%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-247.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.64%
EPS Next Y90.79%
EPS Next 2Y47.89%
EPS Next 3Y32.88%
EPS Next 5Y18.96%
Revenue 1Y (TTM)-9.15%
Revenue growth 3Y2.21%
Revenue growth 5Y-4.74%
Sales Q2Q%17.67%
Revenue Next Year25.26%
Revenue Next 2Y20.57%
Revenue Next 3Y17.11%
Revenue Next 5Y13.88%
EBIT growth 1Y-1098.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year147.92%
EBIT Next 3Y50.05%
EBIT Next 5Y32.37%
FCF growth 1Y-351.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-261.22%
OCF growth 3YN/A
OCF growth 5YN/A